EX-16.1 8 a17-1812_1ex16d1.htm EX-16.1

Exhibit 16.1

 

January 12, 2017

 

Securities and Exchange Commission
Washington, D.C. 20549

 

Commissioners:

 

We have read Marathon Patent Group, Inc.’s statements included under Item 4.01 of its Form 8-K filed on January 12, 2017, and we agree with such statements concerning our firm.

 

/s/ SingerLewak LLP

 

10960 Wilshire Blvd. 7th Floor   Los Angeles, CA 90024   T: 310.477.3924   F: 310.478.6070

 

877.754.4557